Sara Pellegrino | Vice President, Investor Relations & Public Relations |
Fred Vogt | Interim President and Chief Executive Officer |
Igor Bilinsky | Chief Operating Officer |
Jim Ziegler | Senior Vice President, Commercial |
Friedrich Finckenstein | Chief Medical Officer |
Jean-Marc Bellemin | Chief Financial Officer |
Mara Goldstein | Mizuho |
Michael Yee | Jefferies |
Madhu Kumar | Goldman Sachs |
Colleen Kusy | Baird |
Kailie Briza | Stifel |
Nick Abbott | Wells Fargo |
Peter Lawson | Barclays |
Welcome to the Iovance Biotherapeutics Third Quarter and Year-to-Date 2021 Financial Results. My name is Andrew, and I’ll be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] Please note that today’s conference is being recorded.